Dec 6 (Reuters) - Healthequity Inc HQY.O :
* HEALTHEQUITY REPORTS THIRD QUARTER ENDED OCTOBER 31, 2022
FINANCIAL RESULTS
* QTRLY REVENUE OF $216.1 MILLION, AN INCREASE OF 20%
COMPARED TO
$180.0 MILLION IN Q3 FY22
* QTRLY NET LOSS PER DILUTED SHARE OF $0.02
* QTRLY NON-GAAP NET INCOME PER DILUTED SHARE OF $0.38
* Q3 EARNINGS PER SHARE VIEW $0.35, REVENUE VIEW $206.8
MILLION --
REFINITIV IBES DATA
* FOR FISCAL YEAR ENDING JANUARY 31, 2023, MANAGEMENT
EXPECTS
REVENUE OF $850 MILLION TO $860 MILLION
* HEALTHEQUITY - FOR FISCAL YEAR ENDING JAN 31, 2023, SEES
NET
LOSS BETWEEN $34 MILLION-$27 MILLION, RESULTING IN NET LOSS OF
$0.40 - $0.32 PER DILUTED EARNINGS PER SHARE
* SEES NON-GAAP NET INCOME PER DILUTED SHARE OF $1.26 TO
$1.35 FOR
FISCAL YEAR ENDING JAN 31, 2023
* FOR FISCAL YEAR ENDING JANUARY 31, 2024, MANAGEMENT
EXPECTS
REVENUE OF APPROXIMATELY $950 MILLION TO $970 MILLION
Source text for Eikon: ID:nGNX89cNjN
Further company coverage: HQY.O
((Reuters.Briefs@thomsonreuters.com;;))